Abatacept in the treatment of rheumatoid arthritis

por Vital, Edward M, Emery, Paul
Publicado 2006

Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization

por Md Yusof, Md Yuzaiful, Vital, Edward M
Publicado 2021

Abatacept in the treatment of rheumatoid arthritis

por Buch, Maya H, Vital, Edward M, Emery, Paul
Publicado 2008

More to B: the growing evidence to inform targeting B cells in scleroderma

por Bosello, Silvia Laura, Vital, Edward M, Del Galdo, Francesco
Publicado 2022

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

por Romão, Vasco C., Vital, Edward M., Fonseca, João Eurico, Buch, Maya H.
Publicado 2017

Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab

por Hassan, Sabih Ul, Md Yusof, Md Yuzaiful, Emery, Paul, Dass, Shouvik, Vital, Edward M.
Publicado 2020

A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus

por Dörner, Thomas, Vital, Edward M., Ohrndorf, Sarah, Alten, Rieke, Bello, Natalia, Haladyj, Ewa, Burmester, Gerd
Publicado 2022

Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus

por Mahmoud, Khaled, Zayat, Ahmed S, Yusof, Yuzaiful, Hensor, Elizabeth, Conaghan, Philip G, Emery, Paul, Vital, Edward M
Publicado 2019

Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index

por Carter, Lucy M, Gordon, Caroline, Yee, Chee-Seng, Bruce, Ian, Isenberg, David, Skeoch, Sarah, Vital, Edward M
Publicado 2022

TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation

por Psarras, Antonios, Antanaviciute, Agne, Alase, Adewonuola, Carr, Ian, Wittmann, Miriam, Emery, Paul, Tsokos, George C., Vital, Edward M.
Publicado 2021

A glimpse into the future of systemic lupus erythematosus

por Aringer, Martin, Alarcón-Riquelme, Marta E., Clowse, Megan, Pons-Estel, Guillermo J., Vital, Edward M., Dall’Era, Maria
Publicado 2022

Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic

por Marzo-Ortega, Helena, Tan, Ai Lyn, Bissell, Lesley-Anne, Morgan, Ann W, Vandevelde, Claire, Vital, Edward M, Dass, Shouvik
Publicado 2020

Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a singl...

por Md Yusof, Md Yuzaiful, Arnold, Jack, Saleem, Benazir, Vandevelde, Claire, Dass, Shouvik, Savic, Sinisa, Vital, Edward M, Emery, Paul
Publicado 2023

Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus

por Md Yusof, Md Yuzaiful, Shaw, Daniel, El-Sherbiny, Yasser M, Dunn, Emma, Rawstron, Andy C, Emery, Paul, Vital, Edward M
Publicado 2017

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis

por Arnold, Jack, Vital, Edward M., Dass, Shouvik, Aslam, Aamir, Rawstron, Andy C., Savic, Sinisa, Emery, Paul, Md Yusof, Md Yuzaiful
Publicado 2022

Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome

por Pepple, Sophanit, Arnold, Jack, Vital, Edward M., Rawstron, Andrew C., Pease, Colin T., Dass, Shouvik, Emery, Paul, Md Yusof, Md Yuzaiful
Publicado 2022

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil

por Akthar, Mumina, Nair, Nisha, Carter, Lucy M., Vital, Edward M., Sutton, Emily, McHugh, Neil, Bruce, Ian N., Reynolds, John A.
Publicado 2023

Correction: Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolat...

por Akthar, Mumina, Nair, Nisha, Carter, Lucy M., Vital, Edward M., Sutton, Emily, McHugh, Neil, Bruce, Ian N., Reynolds, John A.
Publicado 2023

Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

por Psarras, Antonios, Alase, Adewonuola, Antanaviciute, Agne, Carr, Ian M., Md Yusof, Md Yuzaiful, Wittmann, Miriam, Emery, Paul, Tsokos, George C., Vital, Edward M.
Publicado 2020

De novo lupus nephritis during treatment with belimumab

por Parodis, Ioannis, Vital, Edward M, Hassan, Sabih-Ul, Jönsen, Andreas, Bengtsson, Anders A, Eriksson, Per, Leonard, Dag, Gunnarsson, Iva, Rönnblom, Lars, Sjöwall, Christopher
Publicado 2020